SEPTEMBER 2010, WARSAW, POLAND
The 11th Meeting of the European Calcium Society will take place in Warsaw. This event provides a high quality international forum to meet the needs of calcium researchers, by disseminating latest news on calcium signals in normal and pathological cells. Because this meeting is one of the finest scientific programs in Europe, CreaCell is pleased to lend its support to the ECS on this occasion, and to know that its gift will have a positive impact on the work of future researchers." Preliminary Scientific Program .
The Indian market has tremendous potential and CreaCell has already begun to market its products and services in this country. "To strengthen our links with our existing customers and to explore new opportunities, we will meet, in late April, several Indian CROs and pharmaceutical companies," says Pierre-Yves Perche, CEO of CreaCell. "When our cellular tools are integrated into the drug discovery process of our customers, we are also able to accompany them and to advise them. This moment is important for the final users by giving them the opportunity to quickly optimize theirs processes. It is also important for CreaCell, because the satisfaction of our clients is our goal and it has no boundaries."
JANUARY 2010, MARSEILLE, FRANCE
CreaCell supports the 6th French Symposium of the Pain Research Network on January 22-23 in Marseille. The pain network aims to coordinate the activities of French researchers in the area of pain, to confront the latest advances in clinical research and basic research and to promote exchanges and collaborations between the different teams involved.
NOVEMBER 2009, GRENOBLE, FRANCE
CreaCell has been approved by the French authorities for the Research Tax Credit. This Approval ("Agrément CIR") is valid for 2009, 2010 and 2011. The CIR is based on the claimed volume of R&D expenditures (which include subcontracted R&D). It is equal to 30 % of R&D expenditures up to EUR 100 million; beyond this threshold, the rate comes down to 5 %. For French companies entering the scheme for the first time, the applicable rate is 50 % the first year, and 40 % the second year.
SEPTEMBER
2009, GRENOBLE, FRANCE
CreaCell is a partner of the 20th Conference of the Association "Ion Channels".
Since its creation in 1990, the main objective of the meeting has been to favour scientific interaction between researchers interested in ion channels. This has been achieved through symposia and communications of high scientific level. The Conference will take place in september 2009, on the French Riviera. >Program
APRIL
2009, GRENOBLE, FRANCE
Read our article in "Biotechs Actualités Pharma": Development of high performance stable cell lines (french) (english).
Meet us at Health Ingredients Europe, November 4-6, 2008 - Paris Nord, Villepinte.
OCTOBER
2008, PARIS, FRANCE
Meet us at Bio-Connexion / CRO-Biotech, October 6th, 2008.
APRIL
2008, GRENOBLE, FRANCE
CreaCell completes its offer with Cytogenetics services dedicated to mammalian cells.
Article in "Le Jounal des Entreprises" (french) - MAY 2008
JANUARY
2007, GRENOBLE, FRANCE
CreaCell settles in Biopolis, a seedbed centre located in La Tronche, in vicinity of Grenoble University Hospital and School of Medicine and research laboratories. Biopolis provides us access to technological facilities, including P2 laboratory dedicated to CreaCell's activities.
Article in "Le Jounal des Entreprises" (french) - JUNE 2007
NOVEMBER
2006, SHANGHAI, China
At the end of November CreaCell was in Shanghai in order to discuss terms of a technical partnership with Pr. Ji Zhang from State Key Laboratory of Medical Genomics, Ruijin Hospital.
OCTOBER
2006, PARIS, France
CreaCell at EuroBiO 2006.
EuroBiO 2006, the Tenth European Biotech Crossroads in Paris. Meet us to get informed about the outsoursing of mammalian cell engineering. More information on EuroBiO.
OCTOBER
2006, GRENOBLE, France
October 6th, 2006 - European BioAlpine Convention.
This first edition of European BioAlpine Convention will focus on Neuroscience. More information on European BioAlpine Convention
OCTOBER 2006, GRENOBLE, France
October 5th, 2006 - CreaCell is one of the sponsors of the Annual Topic Day of the Albert Bonniot Institute.
The topic will be "iRNA and repeated sequences, between silence and transcriptional awakening".
In drug discovery, lead optimisation and safety pharmacology, cell line expressing specific ionic channels are powerful tools when combined with patch clamping technologies. With the emergence of dedicated instruments to automated patch-clamping (planar patch clamp technique), CreaCell has started, in partnership with CEA Biochip laboratory, the development of new ion channel cell lines. For more information, please contact us.
CreaCell lanches new service of cell based assays.
The company now offers a new service for leads and targets development. This service is a set of basic functional assays based on mammalian cell lines. CreaCell combines this service with cell line development and cell production to address growing demand it has identified in both pharmaceutical and biotechnology industries. “In vitro functional assays' service integrates our mammalian cell engineering platform and allows these companies to find a more complete solution to outsource the management of their cell biology projects” said Pierre-Yves Perche, CreaCell’s CEO. Press release : article from Biotech Info - L'Usine Nouvelle, march 16th, 2005 (french).
CreaCell joins the CEA Biochip laboratory to develop instruments for automated electrophysiology.
SARL
CreaCell 2010. All rights reserved | Legal
obligations